 Hao Dun
Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tacrolimus | 3 | 2017 | 146 | 0.730 |
Why?
| | Transplantation, Heterotopic | 1 | 2020 | 17 | 0.700 |
Why?
| | Aorta, Abdominal | 1 | 2020 | 45 | 0.690 |
Why?
| | Monocytes | 2 | 2022 | 554 | 0.670 |
Why?
| | Graft Rejection | 5 | 2022 | 569 | 0.640 |
Why?
| | Kidney Transplantation | 6 | 2017 | 638 | 0.630 |
Why?
| | Heart Transplantation | 2 | 2022 | 713 | 0.610 |
Why?
| | Immunosuppressive Agents | 4 | 2017 | 706 | 0.590 |
Why?
| | T-Lymphocytes, Regulatory | 3 | 2017 | 380 | 0.570 |
Why?
| | B-Lymphocytes | 2 | 2020 | 816 | 0.480 |
Why?
| | Receptors, Immunologic | 4 | 2009 | 214 | 0.410 |
Why?
| | Receptors, CCR2 | 1 | 2020 | 39 | 0.410 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2017 | 832 | 0.360 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2017 | 1049 | 0.350 |
Why?
| | Macaca fascicularis | 8 | 2017 | 53 | 0.320 |
Why?
| | Macrophages | 1 | 2022 | 1459 | 0.300 |
Why?
| | Triggering Receptor Expressed on Myeloid Cells-1 | | | 7 | NaN |
Why?
| | Graft Survival | 4 | 2016 | 525 | 0.240 |
Why?
| | Neutrophil Infiltration | | | 103 | NaN |
Why?
| | Arginase | | | 30 | NaN |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | | | 271 | NaN |
Why?
| | Mesenchymal Stem Cell Transplantation | 2 | 2013 | 50 | 0.200 |
Why?
| | Animals | 19 | 2022 | 34733 | 0.200 |
Why?
| | Membrane Glycoproteins | | | 466 | NaN |
Why?
| | Myocardium | 1 | 2020 | 982 | 0.200 |
Why?
| | Mice | 10 | 2022 | 16585 | 0.180 |
Why?
| | Mice, Inbred BALB C | 2 | 2022 | 1241 | 0.180 |
Why?
| | Mice, Inbred C57BL | 8 | 2022 | 5279 | 0.180 |
Why?
| | Phenprocoumon | 1 | 2020 | 4 | 0.180 |
Why?
| | Heart Injuries | 1 | 2020 | 39 | 0.170 |
Why?
| | Disease Models, Animal | 4 | 2017 | 4016 | 0.170 |
Why?
| | Neutrophils | | | 1205 | NaN |
Why?
| | Drug Therapy, Combination | 3 | 2017 | 1024 | 0.160 |
Why?
| | Fatty Acids | 1 | 2022 | 416 | 0.160 |
Why?
| | Acute Lung Injury | 1 | 2022 | 280 | 0.150 |
Why?
| | Positron-Emission Tomography | 1 | 2020 | 284 | 0.150 |
Why?
| | Respiratory Insufficiency | 1 | 2022 | 319 | 0.150 |
Why?
| | Antibodies, Monoclonal | 2 | 2014 | 1360 | 0.140 |
Why?
| | Myocardial Infarction | | | 1032 | NaN |
Why?
| | Receptors, Lysosphingolipid | 1 | 2017 | 14 | 0.140 |
Why?
| | Cell Differentiation | | | 1858 | NaN |
Why?
| | Abatacept | 1 | 2016 | 47 | 0.130 |
Why?
| | Fingolimod Hydrochloride | 1 | 2017 | 36 | 0.130 |
Why?
| | CD40 Antigens | 2 | 2014 | 87 | 0.130 |
Why?
| | Immunoconjugates | 1 | 2016 | 101 | 0.120 |
Why?
| | Immunologic Memory | 1 | 2017 | 335 | 0.120 |
Why?
| | Acute Kidney Injury | 1 | 2022 | 787 | 0.110 |
Why?
| | Mycophenolic Acid | 1 | 2014 | 95 | 0.110 |
Why?
| | Reperfusion Injury | 2 | 2009 | 274 | 0.110 |
Why?
| | Chondrogenesis | 1 | 2013 | 82 | 0.100 |
Why?
| | Knee Injuries | 1 | 2013 | 98 | 0.100 |
Why?
| | Cartilage | 1 | 2013 | 182 | 0.090 |
Why?
| | Regeneration | 1 | 2013 | 177 | 0.090 |
Why?
| | Kidney Failure, Chronic | 1 | 2016 | 548 | 0.090 |
Why?
| | Antilymphocyte Serum | 1 | 2010 | 63 | 0.090 |
Why?
| | Male | 12 | 2022 | 63544 | 0.090 |
Why?
| | Osteoarthritis | 1 | 2013 | 180 | 0.090 |
Why?
| | Mice, Knockout | 1 | 2009 | 2778 | 0.090 |
Why?
| | Urinary Incontinence | 1 | 2010 | 62 | 0.080 |
Why?
| | Knee Joint | 1 | 2013 | 366 | 0.080 |
Why?
| | Sirolimus | 1 | 2010 | 194 | 0.080 |
Why?
| | Ureteral Obstruction | 1 | 2010 | 59 | 0.080 |
Why?
| | Cartilage, Articular | 1 | 2013 | 297 | 0.080 |
Why?
| | Early Growth Response Protein 1 | 1 | 2009 | 27 | 0.080 |
Why?
| | Liver | 2 | 2009 | 1848 | 0.080 |
Why?
| | Allografts | 2 | 2022 | 138 | 0.070 |
Why?
| | Skin | 1 | 2013 | 737 | 0.070 |
Why?
| | Interleukin-10 | 1 | 2009 | 299 | 0.070 |
Why?
| | T-Lymphocyte Subsets | 1 | 2009 | 413 | 0.070 |
Why?
| | Receptor for Advanced Glycation End Products | 4 | 2009 | 29 | 0.060 |
Why?
| | Cell Lineage | 1 | 2005 | 333 | 0.060 |
Why?
| | Inflammation Mediators | 2 | 2006 | 504 | 0.060 |
Why?
| | Liver Regeneration | 1 | 2005 | 39 | 0.060 |
Why?
| | Signal Transduction | 2 | 2006 | 4863 | 0.060 |
Why?
| | Treatment Outcome | 2 | 2017 | 10299 | 0.060 |
Why?
| | NF-kappa B | 2 | 2005 | 687 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2009 | 1208 | 0.050 |
Why?
| | Myocardial Reperfusion Injury | | | 126 | NaN |
Why?
| | Hepatitis | 1 | 2004 | 49 | 0.050 |
Why?
| | Cell Hypoxia | | | 238 | NaN |
Why?
| | Ligands | 2 | 2022 | 615 | 0.050 |
Why?
| | Multiple Sclerosis | 1 | 2009 | 429 | 0.050 |
Why?
| | Flow Cytometry | 2 | 2020 | 1151 | 0.050 |
Why?
| | Reactive Oxygen Species | 1 | 2006 | 579 | 0.050 |
Why?
| | Liver Diseases | 1 | 2006 | 290 | 0.050 |
Why?
| | Ventricular Remodeling | | | 255 | NaN |
Why?
| | Osteopontin | 1 | 2022 | 32 | 0.050 |
Why?
| | Survival Rate | 4 | 2010 | 1894 | 0.050 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2022 | 98 | 0.050 |
Why?
| | Kidney | 2 | 2022 | 1330 | 0.050 |
Why?
| | Isotope Labeling | 1 | 2020 | 73 | 0.040 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 2 | 2010 | 77 | 0.040 |
Why?
| | CD4 Antigens | 2 | 2010 | 137 | 0.040 |
Why?
| | Tissue Donors | 1 | 2022 | 399 | 0.040 |
Why?
| | Humans | 7 | 2022 | 129706 | 0.040 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2014 | 751 | 0.040 |
Why?
| | Bone Marrow Cells | 1 | 2020 | 291 | 0.040 |
Why?
| | Immunophenotyping | 1 | 2020 | 311 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2022 | 1013 | 0.040 |
Why?
| | B7-2 Antigen | 1 | 2016 | 26 | 0.030 |
Why?
| | Female | 2 | 2022 | 68562 | 0.030 |
Why?
| | Kidney Function Tests | 1 | 2016 | 149 | 0.030 |
Why?
| | Phenotype | | | 3063 | NaN |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2016 | 166 | 0.030 |
Why?
| | Transplantation, Homologous | 1 | 2016 | 404 | 0.030 |
Why?
| | CD40 Ligand | 1 | 2014 | 38 | 0.030 |
Why?
| | Biotinylation | 1 | 2014 | 27 | 0.030 |
Why?
| | Antigens, CD20 | 1 | 2014 | 28 | 0.030 |
Why?
| | Colony-Forming Units Assay | 1 | 2013 | 89 | 0.030 |
Why?
| | Collagenases | 1 | 2013 | 23 | 0.030 |
Why?
| | Glomerular Filtration Rate | 1 | 2016 | 684 | 0.030 |
Why?
| | Cell Separation | 1 | 2014 | 313 | 0.030 |
Why?
| | Clone Cells | 1 | 2013 | 257 | 0.030 |
Why?
| | Cytokines | 2 | 2014 | 2008 | 0.020 |
Why?
| | Matrix Metalloproteinases | 1 | 2013 | 90 | 0.020 |
Why?
| | Joints | 1 | 2013 | 97 | 0.020 |
Why?
| | Creatinine | 1 | 2014 | 485 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 828 | 0.020 |
Why?
| | Isoantigens | 1 | 2010 | 14 | 0.020 |
Why?
| | Haplorhini | 1 | 2010 | 57 | 0.020 |
Why?
| | Wound Healing | 1 | 2013 | 310 | 0.020 |
Why?
| | Adoptive Transfer | 1 | 2010 | 221 | 0.020 |
Why?
| | Drug Synergism | 1 | 2010 | 354 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1700 | 0.020 |
Why?
| | Random Allocation | 1 | 2010 | 353 | 0.020 |
Why?
| | Clinical Protocols | 1 | 2010 | 259 | 0.020 |
Why?
| | P-Selectin | 1 | 2009 | 27 | 0.020 |
Why?
| | Chemokine CXCL2 | 1 | 2009 | 45 | 0.020 |
Why?
| | Self Tolerance | 1 | 2009 | 27 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2009 | 130 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 159 | 0.020 |
Why?
| | Postoperative Care | 1 | 2010 | 248 | 0.020 |
Why?
| | Apoptosis | 2 | 2009 | 2485 | 0.020 |
Why?
| | Acute Disease | 1 | 2010 | 984 | 0.020 |
Why?
| | Gene Expression Regulation | 2 | 2009 | 2522 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2010 | 1213 | 0.020 |
Why?
| | Reoperation | 1 | 2010 | 555 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 452 | 0.020 |
Why?
| | Gene Deletion | 1 | 2009 | 376 | 0.020 |
Why?
| | Glycation End Products, Advanced | 1 | 2006 | 62 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2009 | 479 | 0.020 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2006 | 137 | 0.010 |
Why?
| | Transcription Factor AP-1 | 1 | 2004 | 86 | 0.010 |
Why?
| | Hepatectomy | 1 | 2005 | 205 | 0.010 |
Why?
| | Acetaminophen | 1 | 2006 | 255 | 0.010 |
Why?
| | Time Factors | 1 | 2014 | 6593 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2010 | 4058 | 0.010 |
Why?
| | Cell Death | 1 | 2004 | 342 | 0.010 |
Why?
| | Homeostasis | 1 | 2004 | 604 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2004 | 694 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2005 | 2075 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2010 | 2500 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2005 | 2340 | 0.010 |
Why?
| | Risk Factors | 1 | 2010 | 9832 | 0.010 |
Why?
|
|
Dun's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|